[From unexplained fever to visceral leishmaniasis--a case report].

Visceral leishmaniasis or kala-azar is a systemic infectious vector-borne disease caused by protozoa Leishmania donovani and Leishmania infantum that are transmitted to mammalian hosts by sand flies. It occurrs sporadically in endemic areas, including Mediterranean basin. Southern coastal territories of Croatia have been recognized as the foci of the disease. Dogs are the main reservoir of human infection. Clinical features include prolonged fever, malaise, hepatosplenomegaly, pancytopenia and inversion of albumin-globulin ratio. If left untreated, the disease causes death in majority of cases. We report a 47-year-old Croatian patient who was admitted to hospital with 2-month history of fever of unknown origin. Based on bone marrow aspirate findings and positive serological tests, the diagnosis of visceral leishmaniasis was established. We also considered secondary hemophagocytic lymphohystiocytosis in the differential diagnosis. After a 4-week treatment with sodium-stibogluconate clinical remission was achieved as well as complete recovery of hematopoesis. The aim of our case-report is to stress the importance of considering visceral leishmaniasis in patients with longstanding fever in endemic areas.

[1]  G. Matlashewski,et al.  Determinants for the Development of Visceral Leishmaniasis Disease , 2013, PLoS pathogens.

[2]  A. Rodríguez-Morales,et al.  Secondary hemophagocytic lymphohistiocytosis in zoonoses. A systematic review. , 2012, European review for medical and pharmacological sciences.

[3]  R. Kumar,et al.  Immunobiology of visceral leishmaniasis , 2012, Front. Immun..

[4]  Sebastian F N Bode,et al.  Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis , 2012, Arthritis Research & Therapy.

[5]  J. Cano,et al.  Leishmaniasis Worldwide and Global Estimates of Its Incidence , 2012, PloS one.

[6]  N. Ali,et al.  Current diagnosis and treatment of visceral leishmaniasis , 2010, Expert review of anti-infective therapy.

[7]  R. Mulić,et al.  Occurence of visceral and cutaneous leishmaniasis in Croatia. , 2009, Military medicine.

[8]  J. Dujardin,et al.  Molecular Diagnosis of Leishmaniasis: Current Status and Future Applications , 2006, Journal of Clinical Microbiology.

[9]  S. Sundar,et al.  Serological tests for visceral leishmaniasis , 2006, BMJ : British Medical Journal.

[10]  L. Gradoni,et al.  A review of leishmaniasis in Dalmatia (Croatia) and results from recent surveys on phlebotomine sandflies in three southern counties. , 2006, Acta tropica.

[11]  J. Berman,et al.  Advances in leishmaniasis , 2005, The Lancet.

[12]  V. Mrljak,et al.  A seroepidemiologic survey of canine visceral leishmaniosis among apparently healthy dogs in Croatia. , 2005, Veterinary parasitology.

[13]  Shyam Sundar,et al.  Laboratory Diagnosis of Visceral Leishmaniasis , 2002, Clinical and Vaccine Immunology.

[14]  P. Desjeux.  Human leishmaniases: epidemiology and public health aspects. , 1992, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[15]  C J Marinkelle,et al.  The control of leishmaniases. , 1980, Bulletin of the World Health Organization.